CALLAN JMB INC.
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CALLAN JMB INC. | |
| By: | /s/ Wayne Williams |
| Wayne Williams | |
| Chief Executive Officer, President, and Chairman of the Board |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, Wayne Williams and Jeffrey Appleman, and each of them acting individually, as his or her attorney-in-fact, each with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
| SIGNATURE | TITLE | DATE |
|---|---|---|
| /s/ Wayne Williams | Chief Executive Officer, President (Principal Executive Officer) and Chairman of the Board | March 28, 2025 |
| Wayne Williams | ||
| /s/ Jeffrey Appleman | Chief Financial Officer (Principal Financial and Accounting Officer) | March 28, 2025 |
| Jeffrey Appleman | ||
| /s/ David J. Croyle, M.D. | Chief Medical Officer | March 28, 2025 |
| David J. Croyle, M.D. | ||
| /s/ Eric L. Kash | Executive Vice President, and Director | March 28, 2025 |
| Eric L. Kash | ||
| /s/ Mark Meller | Director (Independent) | March 28, 2025 |
| Mark Meller | ||
| /s/ Liberty Duke | Director (Independent) | March 28, 2025 |
| Liberty Duke | ||
| /s/ Gerald Dial | Director (Independent) | March 28, 2025 |
| Gerald Dial | ||
(Formerly Coldchain Technology Services, LLC)
FINANCIAL STATEMENTS AS OF AND FOR
THE YEARS ENDED
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID #089 ) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Stockholders’ / Members Equity for the Years Ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 204 and 2023 | F-6 |
| Notes to the Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.